Evidence of TAVR Benefit Extends to Cardiogenic Shock Evidence of TAVR Benefit Extends to Cardiogenic Shock

Patients in cardiogenic shock should not be excluded from transcatheter aortic valve replacement, despite some early adverse event risk, new registry data suggest.MDedge News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news